Abstract
OBJECTIVE -This retrospective study was designed to identify metabolic and immune predictors of early islet allograft failure. RESEARCH DESIGN AND METHODS -We measured several metabolic and immunological markers at the time of pretransplant and several time points posttransplantation in 17 patients with long-term functioning graft (long fx) and 20 patients with short-term functioning graft (short fx). RESULTS -The short fx group showed higher insulin resistance, altered proinsulin processing, lower soluble interleukin-2 receptor (sIL-2r) (marker of T-cell activation), and higher soluble FasL (marker of apoptosis) during the entire follow-up, particularly at time of failure. CONCLUSIONS -Patients who experienced an early failure of islet allograft showed specific metabolic and immunological signs long before islet failure. © 2008 by the American Diabetes Association.
Cite
CITATION STYLE
Fiorina, P., Vergani, A., Petrelli, A., D’Addio, F., Monti, L., Abdi, R., … Secchi, A. (2008). Metabolic and immunological features of the failing islet-transplanted patient. Diabetes Care, 31(3), 436–438. https://doi.org/10.2337/dc07-1831
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.